85 related articles for article (PubMed ID: 9242462)
1. Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques.
Andreutti-Zaugg C; Scott RJ; Iggo R
Cancer Res; 1997 Aug; 57(15):3288-93. PubMed ID: 9242462
[TBL] [Abstract][Full Text] [Related]
2. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
[TBL] [Abstract][Full Text] [Related]
3. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
Hum Genet; 2005 May; 116(6):538. PubMed ID: 15991314
[No Abstract] [Full Text] [Related]
4. Gene symbol: MSH2. Disease: Hereditary nonpolyposis colorectal cancer.
Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
Hum Genet; 2005 May; 116(6):538. PubMed ID: 15991315
[No Abstract] [Full Text] [Related]
5. Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes.
Marra G; D'Atri S; Yan H; Perrera C; Cannavo' E; Vogelstein B; Jiricny J
Cancer Res; 2001 Nov; 61(21):7719-21. PubMed ID: 11691782
[TBL] [Abstract][Full Text] [Related]
6. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
7. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
8. Detection of heterozygous nonsense mutations in genes of interest using an Escherichia coli-based stop codon assay.
Moon YJ; Kang Y; Choi JH; Lee KH
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):137-43. PubMed ID: 16995837
[TBL] [Abstract][Full Text] [Related]
9. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family.
Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T
Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132
[TBL] [Abstract][Full Text] [Related]
10. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
11. Development of a Premature Stop Codon-detection method based on a bacterial two-hybrid system.
Real SM; Marzese DM; Gomez LC; Mayorga LS; Roqué M
BMC Biotechnol; 2006 Sep; 6():38. PubMed ID: 16948859
[TBL] [Abstract][Full Text] [Related]
12. Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability.
Bateman JF; Freddi S; Lamandé SR; Byers P; Nasioulas S; Douglas J; Otway R; Kohonen-Corish M; Edkins E; Forrest S
Hum Mutat; 1999; 13(4):311-7. PubMed ID: 10220145
[TBL] [Abstract][Full Text] [Related]
13. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.
Noensie EN; Dietz HC
Nat Biotechnol; 2001 May; 19(5):434-9. PubMed ID: 11329012
[TBL] [Abstract][Full Text] [Related]
14. Cancer syndromes and therapy by stop-codon readthrough.
Bordeira-Carriço R; Pêgo AP; Santos M; Oliveira C
Trends Mol Med; 2012 Nov; 18(11):667-78. PubMed ID: 23044248
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring splicing variants of the hMSH2 gene containing nonsense codons identify possible mRNA instability motifs within the gene coding region.
Marshall B; Isidro G; Boavida MG
Biochim Biophys Acta; 1996 Jul; 1308(1):88-92. PubMed ID: 8765755
[TBL] [Abstract][Full Text] [Related]
16. Development of a yeast stop codon assay readily and generally applicable to human genes.
Kataoka A; Tada M; Yano M; Furuuchi K; Cornain S; Hamada J; Suzuki G; Yamada H; Todo S; Moriuchi T
Am J Pathol; 2001 Oct; 159(4):1239-45. PubMed ID: 11583951
[TBL] [Abstract][Full Text] [Related]
17. A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.
Yang C; Feng J; Song W; Wang J; Tsai B; Zhang Y; Scaringe WA; Hill KA; Margaritis P; High KA; Sommer SS
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15394-9. PubMed ID: 17881586
[TBL] [Abstract][Full Text] [Related]
18. Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).
Nagel-Wolfrum K; Möller F; Penner I; Baasov T; Wolfrum U
BioDrugs; 2016 Apr; 30(2):49-74. PubMed ID: 26886021
[TBL] [Abstract][Full Text] [Related]
19. High-throughput in vitro translation.
Diehl F; Traverso G
Discov Med; 2003 Oct; 3(18):44-5. PubMed ID: 20704863
[TBL] [Abstract][Full Text] [Related]
20. The protein truncation test in mutation detection and molecular diagnosis.
Hauss O; Müller O
Methods Mol Biol; 2007; 375():151-64. PubMed ID: 17634601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
